Primary |
Drug Use For Unknown Indication |
23.1% |
Pain |
11.7% |
Neck Pain |
10.6% |
Product Used For Unknown Indication |
9.1% |
Back Pain |
7.2% |
Migraine |
3.8% |
Pain Management |
3.4% |
Anxiety |
3.0% |
Cardiac Disorder |
2.7% |
Hypertension |
2.7% |
Toothache |
2.7% |
Blood Cholesterol |
2.3% |
Chest Pain |
2.3% |
Convulsion |
2.3% |
Crohn's Disease |
2.3% |
Depression |
2.3% |
Diabetes Mellitus |
2.3% |
Foetal Exposure During Pregnancy |
2.3% |
Headache |
2.3% |
Dyspnoea |
1.9% |
|
Suicide Attempt |
12.3% |
Abdominal Pain |
10.8% |
Convulsion |
6.2% |
Drug Toxicity |
6.2% |
Hepatic Cyst |
6.2% |
Somnolence |
6.2% |
Vomiting |
6.2% |
Diabetes Mellitus |
4.6% |
Drug Exposure Via Breast Milk |
4.6% |
Heart Rate Decreased |
4.6% |
Pruritus |
4.6% |
Chronic Hepatitis |
3.1% |
Dementia |
3.1% |
Drug Exposure During Pregnancy |
3.1% |
Dysentery |
3.1% |
Hepatic Failure |
3.1% |
Loss Of Consciousness |
3.1% |
Overdose |
3.1% |
Pain In Extremity |
3.1% |
Speech Disorder |
3.1% |
|
Secondary |
Drug Use For Unknown Indication |
31.3% |
Product Used For Unknown Indication |
10.2% |
Pain |
8.1% |
Back Pain |
5.8% |
Fibromyalgia |
4.1% |
Crohn's Disease |
3.6% |
Chest Pain |
3.4% |
Arthralgia |
3.2% |
Diabetes Mellitus |
3.2% |
Drug Exposure During Pregnancy |
3.2% |
Diuretic Therapy |
3.1% |
Anxiety |
2.9% |
Cardiac Disorder |
2.9% |
Migraine |
2.9% |
Blood Cholesterol Increased |
2.8% |
Convulsion |
1.9% |
Ill-defined Disorder |
1.9% |
Insomnia |
1.9% |
Hypertension |
1.8% |
Gastrooesophageal Reflux Disease |
1.6% |
|
Pancreatic Carcinoma |
13.3% |
Vomiting |
10.7% |
Suicide Attempt |
8.0% |
Nausea |
6.7% |
Abdominal Pain |
5.3% |
Drug Toxicity |
5.3% |
Tooth Abscess |
5.3% |
Amnesia |
4.0% |
Arthritis |
4.0% |
Bedridden |
4.0% |
Emphysema |
4.0% |
Hepatic Enzyme Increased |
4.0% |
Rhabdomyolysis |
4.0% |
Somnolence |
4.0% |
Talipes |
4.0% |
Chills |
2.7% |
Chronic Obstructive Pulmonary Disease |
2.7% |
Drug Dependence |
2.7% |
Drug Exposure Via Breast Milk |
2.7% |
Exposure During Breast Feeding |
2.7% |
|
Concomitant |
Product Used For Unknown Indication |
30.7% |
Drug Use For Unknown Indication |
20.4% |
Pain |
10.6% |
Rheumatoid Arthritis |
5.6% |
Hypertension |
4.5% |
Depression |
3.0% |
Multiple Myeloma |
2.7% |
Crohn's Disease |
2.7% |
Arthritis |
2.7% |
Osteoporosis |
1.7% |
Diabetes Mellitus |
1.7% |
Anxiety |
1.6% |
Arthralgia |
1.6% |
Gastrooesophageal Reflux Disease |
1.6% |
Contraception |
1.5% |
Nausea |
1.5% |
Insomnia |
1.5% |
Headache |
1.5% |
Asthma |
1.5% |
Prophylaxis |
1.5% |
|
Vomiting |
14.2% |
Weight Decreased |
10.0% |
Weight Increased |
7.4% |
Pulmonary Embolism |
5.8% |
Myocardial Infarction |
5.6% |
Urinary Tract Infection |
5.6% |
Pain |
5.4% |
Drug Ineffective |
4.5% |
Nausea |
4.4% |
Pain In Extremity |
4.2% |
Thrombosis |
4.0% |
X-ray Abnormal |
4.0% |
Sepsis |
3.8% |
Deep Vein Thrombosis |
3.6% |
Vision Blurred |
3.6% |
Death |
3.1% |
Headache |
2.7% |
Oedema Peripheral |
2.7% |
Somnolence |
2.7% |
Dyspnoea |
2.5% |
|
Interacting |
Headache |
50.0% |
Smoking Cessation Therapy |
50.0% |
|
Inhibitory Drug Interaction |
25.0% |
Subdural Haematoma |
25.0% |
Syncope |
25.0% |
Vomiting |
25.0% |
|